Editorials
Hematologic diseases History and humanities
Volume 173 - Issue 11

Should we treat leuchaemia in children?

Author:  Peter J Smith

Med J Aust 2000; 173 (11): 568-569.
Published online: 4 December 2000
Share: Share on Blue Sky Share on Facebook Share on LinkedIn Share by email

Editorial

"Should we treat leuchæmia in children?"

Fifty years ago the first controlled clinical trial of cancer chemotherapy was published

Photo of John Colebatch

MJA 2000; 173: 568-569

Author

  • Peter J Smith

References

  1. Colebatch JH, Williams AL. Should we treat leuchæmia in children? Med J Aust 1950; 8: 892-895.
  2. Farber S, Diamond LK, Mercer RD, et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med 1948; 238: 787-793.
  3. Medical Research Council Group. Streptomycin treatment of pulmonary tuberculosis. BMJ 1948; 4582: 769-782.
  4. The controlled therapeutic trial [editorial]. BMJ 1948; 4582: 791-792.
  5. Dameshek W. The use of folic acid antagonists in the treatment of acute and subacute leukemia. Blood 1949; 4: 168-171.
  6. Colebatch JH, Clark ACL, Rice MS, et al. Cyclic drug regime for acute childhood leukaemia. Lancet 1968; 1: 313.
  7. Niemeyer CM, Sallan SE. Acute lymphoblastic leukemia. In: Nathan DG, Orkin SH, editors. Hematology of infancy and childhood. Philadelphia: Saunders, 1998: 1245-1285.